Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 3Phase NA 1Phase 4 1

Status

Terminated 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Classical hematology 2Other 1

Conditions

Venous Thromboembolism 3Neoplasms 3Venous Thrombosis 2Thrombosis 2Pancreatic Neoplasms 2Thromboembolism 1Stomach Neoplasms 1Pulmonary Embolism 1Ovarian Neoplasms 1Obesity 1Multiple Myeloma 1Gliosarcoma 1Glioblastoma 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Embolism and Thrombosis 1Embolism 1Duodenal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 53Bevacizumab 52Cyclophosphamide 49Docetaxel 42Carboplatin 40pembrolizumab 37Paclitaxel 36Fluorouracil 36Cisplatin 35Radiotherapy 31Oxaliplatin 31Capecitabine 29Irinotecan 28Dexamethasone 27Leucovorin 25Cetuximab 25Nivolumab 24Doxorubicin 22Drug Therapy 21Erlotinib Hydrochloride 20Pemetrexed 19durvalumab 18trametinib 17fludarabine 16atezolizumab 16Trastuzumab 16Sunitinib 16Rituximab 16Prednisone 16Sorafenib 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Neoplasms × Dalteparin × Clear all
NCT03297359 2024-01-23

WAVe

Ottawa Hospital Research Institute

Phase 2 Terminated
92 enrolled
Classical hematologyOther

Neoplasms, Obesity, Venous Thromboembolism

NCT00041782 2018-10-31

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

M.D. Anderson Cancer Center

Phase 2 Terminated
26 enrolled

Neoplasms, Venous Thrombosis

NCT01817257 2018-10-29

ALICAT

Cardiff University

Phase 2 Terminated
2 enrolled
Classical hematology

Neoplasms, Pulmonary Embolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡